Inflammatory Responses Completed Phase 3 Trials for Ketamine (DB01221)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01301079Evaluation of the Effect of Ketamine on Remifentanil-induced HyperalgesiaPrevention